Cited by 18

The DOI matches its Crossref record.

Are serum lipid and lipoprotein levels related to dementia?

Cankurtaran, Mustafa, Yavuz, Burcu Balam, Halil, Meltem, Dagli, Neslihan, Cankurtaran, Eylem Sahin, Ariogul, Servet·2005·Archives of Gerontology and Geriatrics

Abstract

Although hyperlipidemia is known to contribute to vascular disease and it may play a role in dementia, specific studies for elderly are limited. The aim of this study is to examine the relationship between dyslipidemia and dementia. In this study, 1251 patients admitted to the Hacettepe University Division of Geriatric Medicine were enrolled. On the basis of the mini mental state examination (MMSE), the clock drawing test (CDT) scores, the APA DSM-IV and the NINCDS-ADRDA criteria and the Hachinski ischemic score (HIS), the subjects were divided into four groups: Alzheimer's disease (AD), vascular dementia (VD), mild cognitive impairment (MCI) and normal cognitive status (NCS). The lipoprotein levels were measured, and we analyzed the data using chi2 and the one-way analysis of variance methods. Among the subjects, 14.8% had low high-density lipoproteins (HDL), 58.5% had high triglyceride (TG), 73.6% had high low-density lipoproteins (LDL), and 21.6% had high lipoprotein-a (Lp(a)) of our study population. There was no difference between the dementia subgroups and the NCS group in the lipoprotein levels. The only significant relationship was between high TG levels and the AD, as well as the MCI groups. Low HDL and high LDL are important problems in elderly. Although serum lipid levels, especially of Lp(a), has recently been thought to be related with dementia, our study suggests the absence of such a relationship. The national data regarding the elderly population should be eva…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.archger.2004.10.008

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 26

  1. American Psychiatric Association (APA), 1994. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. APA Press, Washington, pp. 157–163.
  2. Basset, 2003, Lipoproteins and lipid peroxidation in Alzheimer's disease, J. Nutr. Health Aging, 7, 24
  3. Bonarek, 2000, Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study, Neuroepidemiology, 19, 141, 10.1159/000026249 · DOI
  4. Deanfield, 2003, Clinical trials: evidence and unanswered questions—hyperlipidemia, Cerebrovasc. Dis., 16, 25, 10.1159/000070274 · DOI
  5. Folstein, 1975, “Mini mental state”: a practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  6. Hachinski, 1975, Cerebral blood flow in dementia, Arch. Neorol., 32, 632, 10.1001/archneur.1975.00490510088009 · DOI · Paper page
  7. Heart Protection Study Collaborative Group, 2003. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet 361, 2005–2016. · DOI · Paper page
  8. Hughes, 1982, A new clinical scale for the staging of dementia, Br. J. Psychiatry, 140, 566, 10.1192/bjp.140.6.566 · DOI · Paper page
  9. Lesser, 2001, Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 12, 138, 10.1159/000051248 · DOI
  10. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ARDRA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  11. Merched, 2000, Decreased high density lipoprotein cholesterol and serum apolipoprotein A1 concentrations are highly correlated with the severity of Alzheimer's disease, Neurobiol. Aging, 21, 27, 10.1016/S0197-4580(99)00103-7 · DOI
  12. Michikawa, 2003, Cholesterol paradox: is high total or low HDL cholesterol level risk factor for Alzheimer's disease?, J. Neurosci. Res., 72, 141, 10.1002/jnr.10585 · DOI
  13. Mooser, 2002, Lipoprotein (a) in Alzheimer's atherosclerosis, Rev. Med. Suisse Romande, 120, 903
  14. Mooser, 2000, Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer's disease, Ann. Intern. Med., 132, 533, 10.7326/0003-4819-132-7-200004040-00004 · DOI
  15. Notkola, 1998, Serum total cholesterol, apolipoprotein E ɛ4 allele, and Alzheimer's disease, Neuroepidemiology, 17, 14, 10.1159/000026149 · DOI
  16. Petersen, 1999, Mild cognitive impairment clinical characterization and outcome, Arch. Neurol., 56, 303, 10.1001/archneur.56.3.303 · DOI · Paper page
  17. Scandinavian Simvastatin Survival Study (SSSS) Group, 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383–1389. · DOI
  18. Shepherd, 2002, Prospective study of pravastatin in the elderly at risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial, Lancet, 360, 1623, 10.1016/S0140-6736(02)11600-X · DOI · Paper page
  19. Solfrizzi, 2002, Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease, J. Neurol. Neurosurg. Psychiatry, 72, 732, 10.1136/jnnp.72.6.732 · DOI
  20. Sparks, 2002, Should the guidelines for monitoring serum cholesterol levels in the elderly be re-evaluated?, J. Mol. Neurosci., 19, 209, 10.1007/s12031-002-0035-1 · DOI
  21. Stahelin, 1997, Early diagnosis of dementia via a two-step screening and diagnostic procedure, Int. Psychogeriatry, 9, 123, 10.1017/S1041610297004791 · DOI
  22. Sueyadevara, 2003, J. Gerontol. A: Biol. Sci. Med. Sci., 58, M859, 10.1093/gerona/58.9.M859 · DOI
  23. Tokgozoglu, S.L., 2000. Turk eriskinlerde lipid, lipoprotein ve apolipoproteinler. Onat A. TEKHARF (Turk eriskinlerinde kalp sagligi, risk profili ve kalp hastaligi). Turk Kardiyoloji Dernegi Arsivi, pp. 35–45 (in Turkish).
  24. Urakami, 2000, Lipoprotein(a) phenotypes in patients with vascular dementia, Dement. Geriatr. Cogn. Disord., 11, 135, 10.1159/000017226 · DOI
  25. Zenker, 1986, Lipoprotein(a) as a strong indicator for cerebrovascular disease, Stroke, 17, 942, 10.1161/01.STR.17.5.942 · DOI
  26. Zuliani, G., Blé, A., Zanca, R., Munari, M.R., Zurlo, A., Vavalle, C., Atti, A.R., Fellin, R., 2001. Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease. BioMed. Centr. Geriatr. 1, 5. · DOI

Cited by

Sorted by citations

Metadata

Authors
Cankurtaran, M., Yavuz, B. B., Halil, M., Dagli, N., Cankurtaran, E. S., & Ariogul, S.
Venue
Archives of Gerontology and Geriatrics
Publisher
Elsevier BV
Published
2005-07
Volume
41
Issue
1
Pages
31-39
ISSN
0167-4943
Cited by
18
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review